Fisher & Paykel Healthcare Corporation Limited (FPH.NZ)

NZD 37.7

(-0.4%)

Market Cap (In NZD)

22.09 Billion

Revenue (In NZD)

1.75 Billion

Net Income (In NZD)

132.6 Million

Avg. Volume

409.41 Thousand

Currency
NZD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
22.55-39.21
PE
-
EPS
-
Beta Value
0.387
ISIN
NZFAPE0001S2
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Lewis G. Gradon
Employee Count
-
Website
https://www.fphcare.com
Ipo Date
2000-01-01
Details
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.